PRRT clinical trial at CHU de Québec
We are pleased to announce that this week, we are officially launching our 177Lu-octreotate PRRT clinical trial at CHU de Québec, which is called: Personalized Peptide Receptor Radionuclide Therapy of [...]
Increased Understanding Can Save Lives
CNETS Canada's President, Jackie Herman is quoted in Maclean’s Magazine Digestive Health Supplement
CNETS Research Priorities Survey
This past March CNETS Canada held its first Scientific and Medical Advisory Board (SMAB) meeting in Toronto. The SMAB is composed of prominent Canadian physicians and scientists passionate about the [...]
Neuroendocrine Tumour (NET) Incidence Significantly Increases in Canada
Neuroendocrine Tumour (NET) Incidence Significantly Increases in Canada An original article published in Cancer, February 15, 2015, by the American Cancer Society showed that the incidence of Neuroendocrine Tumours has [...]